Insider Transactions in Q3 2025 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2025
|
Rubric Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,387,225
+7.58%
|
$2,387,225
$1.5 P/Share
|
|
Aug 08
2025
|
Adam Morgan Director |
BUY
Open market or private purchase
|
Indirect |
1,766,546
+16.79%
|
$1,766,546
$1.5 P/Share
|
|
Jul 31
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,695
+7.2%
|
-
|
|
Jul 31
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,695
+6.65%
|
-
|
|
Jul 31
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,789
+6.83%
|
-
|
|
Jul 19
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+2.71%
|
-
|
|
Jul 19
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,874
+2.48%
|
-
|
|
Jul 19
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,797
+3.04%
|
-
|